Jon Spiro
Overview
    Explore the profile of Jon Spiro including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              12
            
            
              Citations
              59
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Rasmussen L, Schmidt S, Knuuti J, Spiro J, Rajwani A, Lopes P, et al.
  
  
    Eur Heart J Cardiovasc Imaging
    . 2025 Feb;
    
    PMID: 39918232
  
  
          Aims: Models predicting the likelihood of obstructive coronary artery disease (CAD) on invasive coronary angiography (ICA) exist. However, as stable patients with new-onset chest pain frequently have lower clinical likelihood...
      
2.
        
    
    Spiro J, Ford T, Yong A, Zeitz C, Beltrame J
  
  
    Heart Lung Circ
    . 2024 Jul;
          33(9):1287-1296.
    
    PMID: 38951052
  
  
          Background: Functional coronary angiography (FCA) for endotype characterisation (vasospastic angina [VSA], coronary microvascular disease [CMD], or mixed) is recommended among patients with angina with non-obstructive coronary arteries. Whilst clear diagnostic...
      
3.
        
    
    Ng P, Spiro J, Shiekh I, Schultz C, Alcock R
  
  
    JACC Case Rep
    . 2024 Jan;
          28:102127.
    
    PMID: 38204542
  
  
          Coronary artery spasm remains an important yet rarely recognized cause of myocardial ischemia, which may manifest as vasospastic angina, ventricular arrhythmia, or sudden cardiac death. Here we present a case...
      
4.
        
    
    Charng J, Attia M, Arunachalam S, Lam W, Creaney J, Muruganandan S, et al.
  
  
    Clin Exp Ophthalmol
    . 2021 May;
          49(6):579-590.
    
    PMID: 33934469
  
  
          Background: To describe ocular adverse events and retinal changes during fibroblast growth factor receptor (FGFR) inhibitor (AZD4547) anticancer therapy. Methods: This is a sub-study examining ocular adverse effects from AZD4547...
      
5.
        
    
    Majeed K, Bellinge J, Butcher S, Alcock R, Spiro J, Playford D, et al.
  
  
    Atherosclerosis
    . 2020 Dec;
          319:142-148.
    
    PMID: 33358367
  
  
          Background And Aims: F-Sodium Fluoride Positron Emission Tomography (F-NaF PET) non-invasively detects micro-calcification activity, the earliest stage of atherosclerotic arterial calcification. We studied the association between coronary F-NaF uptake and...
      
6.
        
    
    Lam W, Creaney J, Chen F, Chin W, Muruganandan S, Arunachalam S, et al.
  
  
    Lung Cancer
    . 2020 Jan;
          140:87-92.
    
    PMID: 31901768
  
  
          Objectives: Currently, there is no optimal salvage therapy for patients with malignant pleural mesothelioma (MPM) who relapse after treatment with first-line chemotherapy. In line with the strong preclinical rationale for...
      
7.
        
    
    Majeed K, Hartman E, Mori T, Alcock R, Spiro J, Ligthart J, et al.
  
  
    Heart Lung Circ
    . 2019 Jul;
          29(6):874-882.
    
    PMID: 31353214
  
  
          Background: Optical coherence tomography (OCT) can detect detailed plaque features in native coronary arteries. Stent struts cause shadows that partially obscure the vessel wall, but plaque features can still be...
      
8.
        
    
    Venugopal V, Spiro J, Zaphiriou A, Khan S, Townend J, Ludman P, et al.
  
  
    Cardiol Ther
    . 2014 Dec;
          4(1):47-58.
    
    PMID: 25515965
  
  
          Aims: The Impella is a percutaneous ventricular assist device. The majority of published data describes the 2.5L and 5.0L devices, and little data is available for the newer 3.8L device....
      
9.
        
    
    Spiro J, Doshi S
  
  
    Curr Cardiol Rep
    . 2014 Oct;
          16(12):544.
    
    PMID: 25326728
  
  
          In an effort to improve outcomes in percutaneous coronary intervention (PCI), percutaneous ventricular assist devices (PVADs) have been investigated in (1) high-risk PCI, (2) acute myocardial infarction (AMI) complicated by...
      
10.
        
    
    Spiro J, Theodosiou M, Doshi S
  
  
    Emerg Nurse
    . 2014 Feb;
          21(9):28-30.
    
    PMID: 24494769
  
  
          Rates of survival after cardiac arrest are low and correlate with the quality of cardiopulmonary resuscitation (CPR). Devices that deliver automated CPR (A-CPR) can provide sustained and effective chest compressions,...